scholarly journals Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial

Cancer ◽  
2019 ◽  
Vol 126 (6) ◽  
pp. 1175-1182
Author(s):  
Antroula Papakonstantinou ◽  
Alexios Matikas ◽  
Nils Olof Bengtsson ◽  
Per Malmström ◽  
Elham Hedayati ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Efficacy And Safety ◽  
Her2 Positive ◽  
Phase 3 ◽  
Her2 Positive Breast Cancer ◽  
Dose Dense ◽  
Positive Breast Cancer

scholarly journals Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

2016 ◽  
pp. 959 ◽  
Author(s):  
Bo Ma ◽  
Qianqian Ma ◽  
Xiaohong Wang ◽  
Guolei Zhang ◽  
Huiying Zhang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Efficacy ◽  
Efficacy And Safety ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer

2019 ◽  
Vol 17 (1) ◽  
pp. 47-56 ◽  
Author(s):  
Zachary Veitch ◽  
Omar F. Khan ◽  
Derek Tilley ◽  
Domek Ribnikar ◽  
Xanthoula Kostaras ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Real World ◽  
Her2 Positive ◽  
Node Negative ◽  
Node Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

2005 ◽  
Vol 353 (16) ◽  
pp. 1659-1672 ◽  
Author(s):  
Martine J. Piccart-Gebhart ◽  
Marion Procter ◽  
Brian Leyland-Jones ◽  
Aron Goldhirsch ◽  
Michael Untch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document